Physician profile
Jonathan Daniel Chodroff
NPI 1366950594
$3,012.24
in general payments reported to CMS, 2019-2025
13 companies · $626 in 2025
The $626 reported for 2025 was more than what 81% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $127 · 2021: $232 · 2022: $753 · 2023: $697 · 2024: $309 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Gift: $108 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.74 |
| Gift | $108.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $780.96 | 2019-2022 | |
| Straumann USA LLC | $580.96 | 2023-2025 | |
| Zimvie INC. | $479.47 | 2025 | |
| Depuy Synthes Sales INC. | $363.48 | 2021-2023 | Trumatch, Matrixorthognathic |
| Axogen | $318.27 | 2022-2023 | Avance Nerve Graft |
| Merck Sharp & Dohme LLC | $105.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $103.22 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $97.07 | 2024-2025 | Exparel |
| Biohorizons Implant Systems INC. | $85.36 | 2025 | Biohorizons Dental Implants |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $34.18 | 2023 | |
| Medical Device Business Services, INC. | $24.17 | 2019 | |
| Kci USA, INC. | $22.15 | 2021 | |
| Patterson Companies, INC. | $17.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chodroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.